PATENT IMPROVES RUBELLA TESTING ACCURACY

Meridian Bioscience announced that Viral Antigens, a wholly owned life science subsidiary, received a patent entitled "Specificity in the Detection of Anti-Rubella IgM Antibodies" from the U.S. Patent and Trademark Office. This patent encompasses improved methods for detection of anti-rubella IgM antibodies in commercial diagnostic products, utilized to test blood samples for the presence of rubella antibodies.

()a href="http://menafn.com/qn_news_story.asp?StoryId=CqRJIqbKbmtCZyJC2mti" target="_blank">MENAFN